Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ehsan Jazini

Orthopaedic Surgery of the Spine Reston, VA Medical Doctor

NPI 1568758951 CMS profile 1579727

11800 Sunrise Valley Dr Ste 600, Reston, VA 20191

Open in the dashboard

General payments

$501,580

328 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ehsan Jazini of Reston, VA is reported in the CMS Open Payments database as having received $501,580 across 328 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $31,912 20
2024 General $221,480 94
2023 General $61,304 37
2022 General $82,993 74
2021 General $58,896 34
2020 General $24,526 34
2019 General $20,469 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ehsan Jazini
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Ehsan Jazini were reported at $31,912. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Ehsan Jazini Orthopaedic Surgery of the Spine median Middle half National median
2019 $20,469 $2,106 $337–$18,608 $163
2020 $24,526 $1,213 $156–$15,082 $114
2021 $58,896 $1,834 $271–$15,617 $132
2022 $82,993 $2,015 $320–$17,036 $149
2023 $61,304 $1,925 $336–$14,599 $160
2024 $221,480 $2,110 $341–$12,483 $164
2025 $31,912 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stability Biologics, LLC $212,254 38 payments
  2. Innovasis Inc $83,076 60 payments
  3. Centinel Spine, LLC $76,232 32 payments
  4. Medacta USA, Inc. $45,105 45 payments
  5. Medtronic USA, Inc. $29,810 49 payments
  6. Medtronic, Inc. $13,610 29 payments
  7. Precision Spine, Inc. $12,944 6 payments
  8. Kuros Biosciences USA, Inc $8,240 9 payments
  9. Orthofix Medical, Inc. $6,734 8 payments
  10. Stryker Corporation $4,281 6 payments
  11. Other $9,295 46 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $398,840 100 payments
  2. Travel and Lodging $47,488 68 payments
  3. Food and Beverage $32,154 147 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $23,039 12 payments
  5. Education $60 1 payment
Products named General payments · program years 2019–2025
  1. PRODISC L $43,795 19 payments
  2. MySpine Spine $33,729 22 payments
  3. PRODISC C $20,440 5 payments
  4. CD HORIZON $14,939 16 payments
  5. SLIMPLICITY HP $13,500 2 payments
  6. MAZOR X SYSTEM $10,687 20 payments
  7. MAGNETOS $8,240 9 payments
  8. MySpine Orthopedics/Orthopedic Surgery $7,150 4 payments
  9. Reform Modular Cortical Screw System $6,750 1 payment
  10. Next Gen Reform MIS $6,750 1 payment
  11. Other $69,231 149 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

75

Median for Orthopedic Surgery: 203

Drug cost

$545

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 15 $161
Methylprednisolone Generic 24 $156
Methocarbamol Generic 12 $93
Tizanidine Hcl Generic 12 $84
Cyclobenzaprine Hcl Generic 12 $51

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 61 billing codes

Paid by Medicare

$111,856

Medicare's payments for the services billed

Medicare patients

85

Average age 71

Services billed

554

34 women, 51 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Ischemic heart disease 31%
Diabetes 29%
Osteoporosis 24%
Depression 22%
Chronic kidney disease 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

328 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record